Senseonics was made aware of an incident where patient developed infection at insertion site.At the beginning of week of (b)(6) , patient noticed that the area became harder than usual, but she did not notice any signs of redness or heat.This was treated with anti-inflammatory medication (ibuprofen) and she noticed improvement.Later she noticed that the area itched abnormally during the night.Then on (b)(6) 2022, the user noticed after removing the transmitter the area began to ooze.The incision site was open.Her physician recommended to stop wearing the transmitter.She went to see her doctor on (b)(6) 2022 and the doctor recommended to remove the sensor.
|
This report is being submitted retrospectively as part of internal review.Senseonics was made aware of an incident where patient developed infection at insertion site.At the beginning of week of (b)(6) , patient noticed that the area became harder than usual, but she did not notice any signs of redness or heat.This was treated with anti-inflammatory medication (ibuprofen) and she noticed improvement.Later she noticed that the area itched abnormally during the night.Then on (b)(6) 2022, the user noticed after removing the transmitter the area began to ooze.The incision site was open.Her physician recommended to stop wearing the transmitter.She went to see her doctor on (b)(6) 2022 and the doctor recommended to remove the sensor.
|